Skip to main content

Mechanisms of Inflammation in Lung Tissue

  • Chapter
  • 56 Accesses

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 134))

Abstract

Inflammation can be seen as a balance of pro-inflammatory and anti-inflammatory reactions, with pro-inflammatory reactions involved in the initiation and amplification of inflammation via mediators (chemotactic and vasopermeability factors) and tissue injury (by loss of cell function and death). Anti-inflammatory reactions, on the other hand, will suppress inflammation by inactivation of these mediators (via chemotactic factor inactivator [CFI] and anaphylatoxin inactivator), thus reducing the delivery of destructive enzymes and products of activated leukocytes (1). Although basic mechanisms of inflammatory processes are beginning to be reasonably well understood in the kidney, relatively little is known about inflammation in the lung. Insult to the lung, whether immunologic, infectious or environmental, often will activate intrinsic systems such as the complement system, which generates vasopermeability and chemotactic factors. These factors will recruit leukocytes and serum factors into the lung which will directly damage lung structure and function. In addition, these recruited leukocytes have the potential capacity to amplify inflammatory reactions and tissue injury by various mechanisms: 1. release of lysosomal enzymes; 2. production of free radicals and other factors that damage structural elements; 3. the activation or direct cleavage of complement, complement components, or other lung constituents into active chemotactic factors; 4. activation of other inflammatory pathways such as coagulation; and 5. stimulation of resident lung cells such as macrophages or type II cells to elaborate preformed (chemotactic factors) and precursor (C3 and C5) inflammatory mediators which would increase the recruitment of leukocytes (PMN’s and monocytes) into the lung. At the same time, anti-inflammatory modulators such as the CFI system (serum and cell-derived CFI’s) serve to regulate and limit the inflammatory reactions by inactivating the chemotactic factors, thus blocking the influx of leukocytes into the lung (2). When pro-inflammatory and anti-inflammatory reactions are properly balanced, inflammation will occur with minimal damage to healthy tissue. Uncontrolled, these inflammatory reactions can destroy healthy tissue with resulting loss of normal lung architecture and function.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ward, P.A. In: Granulocyte Physiology Function and Dysfunction, ed. Beckman. American Association of Blood Banks (1979) 35.

    Google Scholar 

  2. Kreutzer, D.L. et al. Clin Immunol Immunopathol 12 (1979) 162.

    Article  PubMed  CAS  Google Scholar 

  3. Ward, P.A. et al. J Exp Med 122 (1965) 327.

    Article  PubMed  CAS  Google Scholar 

  4. Showeil, H.J. et al. J Exp Med 143 (1976) 1154.

    Article  Google Scholar 

  5. Fernandez, H.N. et al. J Immunol 120 (1978) 109.

    PubMed  CAS  Google Scholar 

  6. Schiffman, E. et al. Proc Natl Acad Sci USA 72 (1975) 1059.

    Article  Google Scholar 

  7. Kreutzer, D.L. et al. Immunopharmacol 1 (1979) 39.

    Article  Google Scholar 

  8. Tack, B.F.; Prahl, J.W. Biochemistry 15 (1976) 4513.

    Article  PubMed  CAS  Google Scholar 

  9. Schreiber, R.D.; Müller-Eberhard, H.J. J Exp Med 140 (1974) 1324.

    Article  PubMed  CAS  Google Scholar 

  10. Krohn, K. et al. Biochem Biophys Acta 285 (1972) 404.

    Article  PubMed  CAS  Google Scholar 

  11. Kreutzer, D.L. et al. Chest 75 (1979) 259.

    PubMed  CAS  Google Scholar 

  12. Desai, U. et al. Am J Pathol 96 (1979) 71.

    PubMed  CAS  Google Scholar 

  13. Ward, P.A.; Hill, J.H. Proc Soc Exp Biol Med 141 (1972) 898.

    PubMed  CAS  Google Scholar 

  14. Colten, H.R. Adv Immunol 22 (1976) 67.

    Article  PubMed  CAS  Google Scholar 

  15. Desai, U. et al. Am J Pathol (in press).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Plenum Press, New York

About this chapter

Cite this chapter

Kreutzer, D.L., Desai, U., Douglas, W.H.J., Blazka, M. (1981). Mechanisms of Inflammation in Lung Tissue. In: Wayne Streilein, J., Hart, D.A., Stein-Streilein, J., Duncan, W.R., Billingham, R.E. (eds) Hamster Immune Responses in Infectious and Oncologic Diseases. Advances in Experimental Medicine and Biology, vol 134. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0495-2_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-0495-2_21

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-0497-6

  • Online ISBN: 978-1-4757-0495-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics